1. Home
  2. AQST vs AAM Comparison

AQST vs AAM Comparison

Compare AQST & AAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • AAM
  • Stock Information
  • Founded
  • AQST 2004
  • AAM 2024
  • Country
  • AQST United States
  • AAM United States
  • Employees
  • AQST N/A
  • AAM N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • AAM
  • Sector
  • AQST Health Care
  • AAM
  • Exchange
  • AQST Nasdaq
  • AAM Nasdaq
  • Market Cap
  • AQST 390.4M
  • AAM 460.0M
  • IPO Year
  • AQST 2018
  • AAM 2024
  • Fundamental
  • Price
  • AQST $3.77
  • AAM $10.48
  • Analyst Decision
  • AQST Strong Buy
  • AAM
  • Analyst Count
  • AQST 6
  • AAM 0
  • Target Price
  • AQST $10.67
  • AAM N/A
  • AVG Volume (30 Days)
  • AQST 1.4M
  • AAM 79.3K
  • Earning Date
  • AQST 08-11-2025
  • AAM 01-01-0001
  • Dividend Yield
  • AQST N/A
  • AAM N/A
  • EPS Growth
  • AQST N/A
  • AAM N/A
  • EPS
  • AQST N/A
  • AAM 0.32
  • Revenue
  • AQST $44,132,000.00
  • AAM N/A
  • Revenue This Year
  • AQST N/A
  • AAM N/A
  • Revenue Next Year
  • AQST $38.71
  • AAM N/A
  • P/E Ratio
  • AQST N/A
  • AAM $32.54
  • Revenue Growth
  • AQST N/A
  • AAM N/A
  • 52 Week Low
  • AQST $2.12
  • AAM $9.96
  • 52 Week High
  • AQST $5.80
  • AAM $10.79
  • Technical
  • Relative Strength Index (RSI)
  • AQST 44.00
  • AAM 52.77
  • Support Level
  • AQST $3.85
  • AAM $10.47
  • Resistance Level
  • AQST $4.13
  • AAM $10.49
  • Average True Range (ATR)
  • AQST 0.25
  • AAM 0.02
  • MACD
  • AQST -0.03
  • AAM -0.00
  • Stochastic Oscillator
  • AQST 13.79
  • AAM 60.00

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About AAM AA Mission Acquisition Corp. Class A Ordinary Shares

AA Mission Acquisition Corp is a blank check company.

Share on Social Networks: